Literature DB >> 23382540

Cardiopulmonary exercise testing reflects similar pathophysiology and disease severity in heart failure patients with reduced and preserved ejection fraction.

Marco Guazzi1, Valentina Labate2, Lawrence P Cahalin3, Ross Arena4.   

Abstract

BACKGROUND: We are unaware of any previous investigation that has compared the relationship of key cardiopulmonary exercise testing (CPX) variables to various measures of pathophysiology between heart failure-reduced ejection fraction (HFrEF) and HF-preserved ejection fraction (HFpEF) cohorts that are well matched with respect to baseline characteristics and their exercise response, which is the purpose of the present study.
METHODS: Thirty-four patients with HFpEF were randomly matched to 34 subjects with HFrEF according to age and sex as well as peak oxygen consumption (VO2), ventilatory efficiency (VE/VCO2 slope), and exercise oscillatory ventilation (EOV). In addition to CPX, patients also underwent echocardiography with tissue Doppler imaging (TDI) and assessment of N-terminal pro-B-type natriuretic peptide (NT-proBNP).
RESULTS: When matched for age, sex, and CPX variables, the HFrEF and HFpEF cohorts had similar echocardiography with TDI and NT-proBNP values, indicating comparable disease severity. In addition, the correlations between key CPX measures (peak VO2 and VE/VCO2 slope) and echocardiography with TDI and NT-proBNP measures were similar between HFrEF and HFpEF groups. Of note, the correlation between the VE/VCO2 slope and pulmonary artery systolic pressure and NT-proBNP was highly significant in both groups (r ≥ 0.65, p < 0.01). Moreover, subjects with EOV in both groups had a significantly higher PASP (∼47 vs. ∼35 mmHg, p < 0.05).
CONCLUSIONS: The results of the current study indicate CPX equally represents disease severity in HFrEF and HFpEF patients. This is a novel finding supporting the key role of CPX in the clinical follow-up of HF patients irrespective of LVEF and cardiac phenotype. © The European Society of Cardiology 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Diastolic; systolic; ventilatory expired gas; ventricle

Mesh:

Substances:

Year:  2013        PMID: 23382540     DOI: 10.1177/2047487313476962

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  8 in total

1.  Relation of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease to Left Ventricular Diastolic Function and Exercise Tolerance.

Authors:  Justin McNair Canada; Antonio Abbate; Rebecca Collen; Hayley Billingsley; Leo Francis Buckley; Salvatore Carbone; Cory Ross Trankle; Michael Ola Idowu; Dinesh Kadariya; Benjamin Van Tassell; Arun Jayant Sanyal; Mohammad Shadab Siddiqui
Journal:  Am J Cardiol       Date:  2018-11-06       Impact factor: 2.778

2.  Clinical predictors of response to anakinra in patients with heart failure.

Authors:  Justin M Canada; Benjamin W Van Tassell; Sanah Christopher; Claudia Oddi; Nayef A Abouzaki; Michael L Gambill; George Mueller; Ryan Melchior; Keyur B Shah; Charles A Dinarello; Antonio Abbate; Ross Arena
Journal:  Int J Cardiol       Date:  2014-03-15       Impact factor: 4.164

3.  Hemodynamic Correlates and Diagnostic Role of Cardiopulmonary Exercise Testing in Heart Failure With Preserved Ejection Fraction.

Authors:  Yogesh N V Reddy; Thomas P Olson; Masaru Obokata; Vojtech Melenovsky; Barry A Borlaug
Journal:  JACC Heart Fail       Date:  2018-05-23       Impact factor: 12.035

4.  Left ventricular concentric remodeling and impaired cardiorespiratory fitness in patients with heart failure and preserved ejection fraction.

Authors:  Justin Heizer; Salvatore Carbone; Hayley E Billingsley; Benjamin W VAN Tassell; Ross Arena; Antonio Abbate; Justin M Canada
Journal:  Minerva Cardiol Angiol       Date:  2020-09-30

5.  Prognostic value of cardiopulmonary exercise testing in heart failure with preserved ejection fraction. The Henry Ford HospITal CardioPulmonary EXercise Testing (FIT-CPX) project.

Authors:  Ali Shafiq; Clinton A Brawner; Heather A Aldred; Barry Lewis; Celeste T Williams; Christina Tita; John R Schairer; Jonathan K Ehrman; Mauricio Velez; Yelena Selektor; David E Lanfear; Steven J Keteyian
Journal:  Am Heart J       Date:  2016-01-12       Impact factor: 4.749

6.  Exercise ventilatory inefficiency in heart failure and chronic obstructive pulmonary disease.

Authors:  Joshua R Smith; Erik H Van Iterson; Bruce D Johnson; Barry A Borlaug; Thomas P Olson
Journal:  Int J Cardiol       Date:  2018-09-05       Impact factor: 4.164

7.  Distinguishing exercise intolerance in early-stage pulmonary hypertension with invasive exercise hemodynamics: Rest VE /VCO2 and ETCO2 identify pulmonary vascular disease.

Authors:  Farhan Raza; Naga Dharmavaram; Timothy Hess; Ravi Dhingra; James Runo; Amy Chybowski; Callyn Kozitza; Supria Batra; Evelyn M Horn; Naomi Chesler; Marlowe Eldridge
Journal:  Clin Cardiol       Date:  2022-04-14       Impact factor: 3.287

8.  Left atrial function and maximal exercise capacity in heart failure with preserved and mid-range ejection fraction.

Authors:  Caterina Maffeis; Daniel Armando Morris; Evgeny Belyavskiy; Martin Kropf; Aravind Kumar Radhakrishnan; Veronika Zach; Cristina Rozados da Conceicao; Tobias Daniel Trippel; Elisabeth Pieske-Kraigher; Andrea Rossi; Burkert Pieske; Frank Edelmann
Journal:  ESC Heart Fail       Date:  2020-12-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.